The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
Clinical trial NCT02414165 · TERMINATED
Trial details
- NCT number
- NCT02414165
- Sponsor
- Tocagen Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-30
- Primary completion
- 2019-05-31
- Enrollment
- 403
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.